- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
As the global economy mends, the 2021 growth of Induced Pluripotent Stem Cells (iPSCs) will have significant change from previous year. According to our latest study, the global Induced Pluripotent Stem Cells (iPSCs) market size is USD million in 2022 from USD 99.3 million in 2021, with a change of % between 2021 and 2022. The global Induced Pluripotent Stem Cells (iPSCs) market size will reach USD 230.1 million in 2028, growing at a CAGR of 12.8% over the analysis period.
The United States Induced Pluripotent Stem Cells (iPSCs) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Induced Pluripotent Stem Cells (iPSCs) market, reaching US$ million by the year 2028. As for the Europe Induced Pluripotent Stem Cells (iPSCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Induced Pluripotent Stem Cells (iPSCs) players cover Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, and Astellas Pharma Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Human iPSCs
Mouse iPSCs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2017-2028
2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.4.1 Academic Research
2.4.2 Drug Development and Discovery
2.4.3 Toxicity Screening
2.4.4 Regenerative Medicine
2.4.5 Others
2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.5.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Player
3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2020-2022)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2020-2022)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Induced Pluripotent Stem Cells (iPSCs) by Regions
4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2017-2022)
4.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2017-2022)
4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2017-2022)
4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2017-2022)
4.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022)
5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022)
6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) by Country (2017-2022)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Region (2017-2022)
8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2023-2028)
10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2023-2028)
10.1.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2023-2028)
10.2.1 United States Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.2 Canada Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.3 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.4 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2023-2028)
10.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.2 Japan Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.3 Korea Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.6 Australia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2023-2028)
10.4.1 Germany Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.2 France Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.3 UK Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.4 Italy Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.5 Russia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2023-2028)
10.5.1 Egypt Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.2 South Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.4 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.5 GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.6 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2023-2028)
10.7 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Information
11.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview
11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments
11.2 Ncardia
11.2.1 Ncardia Company Information
11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ncardia Main Business Overview
11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Information
11.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sumitomo Dainippon Pharma Main Business Overview
11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Information
11.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Fate Therapeutics, Inc Main Business Overview
11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Information
11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pluricell Biotech Main Business Overview
11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Information
11.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Cell Inspire Biotechnology Main Business Overview
11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Information
11.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ReproCELL Main Business Overview
11.8.5 ReproCELL Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Human iPSCs
Table 3. Major Players of Mouse iPSCs
Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
Table 7. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2020-2022)
Table 12. Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2017-2022)
Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
Table 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2017-2022)
Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
Table 30. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2017-2022)
Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Induced Pluripotent Stem Cells (iPSCs)
Table 43. Key Market Challenges & Risks of Induced Pluripotent Stem Cells (iPSCs)
Table 44. Key Industry Trends of Induced Pluripotent Stem Cells (iPSCs)
Table 45. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2023-2028)
Table 51. Fujifilm Holding Corporation (CDI) Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 52. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Fujifilm Holding Corporation (CDI) Main Business
Table 55. Fujifilm Holding Corporation (CDI) Latest Developments
Table 56. Ncardia Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 57. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 58. Ncardia Main Business
Table 59. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Ncardia Latest Developments
Table 61. Sumitomo Dainippon Pharma Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 62. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 63. Sumitomo Dainippon Pharma Main Business
Table 64. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Sumitomo Dainippon Pharma Latest Developments
Table 66. Astellas Pharma Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 67. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 68. Astellas Pharma Inc Main Business
Table 69. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Astellas Pharma Inc Latest Developments
Table 71. Fate Therapeutics, Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 72. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 73. Fate Therapeutics, Inc Main Business
Table 74. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Fate Therapeutics, Inc Latest Developments
Table 76. Pluricell Biotech Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 77. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 78. Pluricell Biotech Main Business
Table 79. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Pluricell Biotech Latest Developments
Table 81. Cell Inspire Biotechnology Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 82. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 83. Cell Inspire Biotechnology Main Business
Table 84. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Cell Inspire Biotechnology Latest Developments
Table 86. ReproCELL Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 87. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 88. ReproCELL Main Business
Table 89. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. ReproCELL Latest Developments
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2021
Figure 7. Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 8. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2017-2022) & ($ Millions)
Figure 9. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2017-2022) & ($ Millions)
Figure 11. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2017-2022) & ($ Millions)
Figure 13. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2017-2022) & ($ Millions)
Figure 15. Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2021
Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2021
Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2017-2022 ($ Millions)
Figure 21. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2017-2022 ($ Millions)
Figure 22. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2017-2022 ($ Millions)
Figure 24. Americas Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2021
Figure 25. Americas Induced Pluripotent Stem Cells (iPSCs) Consumption Market Share by Type in 2021
Figure 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2021
Figure 27. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2021
Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2021
Figure 33. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2021
Figure 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2021
Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2021
Figure 42. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2021
Figure 50. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 56. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 57. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 59. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 60. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 63. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 64. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 65. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 67. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 68. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 69. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 70. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 71. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 72. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 73. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 74. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 77. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2023-2028 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
